Northwest Biotherapeutics Cash Flow Statement (2010-2025) | NWBO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-21.02M	-13.21M	-11.65M	-11.83M	-14.19M	-22.53M	-17.13M	-19.40M	-13.99M	-14.88M	-15.49M	-16.38M	-17.26M	-19.14M	-16.88M	27.93M	-18.91M	-16.61M	-16.94M	30.58M
Depreciation and Depletion (Quarter)					0.10M	0.50M	0.30M	0.40M	0.30M	0.40M	0.40M	0.40M	0.40M	0.50M
Share-based Compensation (Quarter)	9.82M	3.55M	1.26M	0.87M	0.62M	5.76M	3.36M	2.56M	0.93M	0.28M	1.62M	1.57M	1.16M	1.15M	0.69M	0.45M	0.39M	0.36M	0.27M	0.18M
Gains from Investment Securities (Quarter)				304.85M			304.60M
Non-cash Items (Quarter)	-6.45M	-13.45M	-56.38M	-143.87M	0.64M	11.41M	114.62M	16.04M	-0.53M	1.69M	9.46M	2.04M	2.63M	0.84M	7.34M	5.95M	3.54M	3.82M	10.29M	-15.22M
Cash from Operations (Quarter)	-13.25M	-6.79M	-7.01M	-11.25M	-12.97M	-14.84M	-16.12M	-8.85M	-11.24M	-11.52M	-13.92M	-16.96M	-12.41M	-16.20M	-8.23M	-20.18M	-9.42M	-6.69M	-13.89M	-14.76M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	0.09M	0.06M	0.06M				0.06M		0.07M	0.07M	0.07M		0.08M	0.08M	0.08M	0.06M	0.06M	0.07M	0.07M	0.07M
Amortization of Deferred Charges (Quarter)	1.13M	0.23M	0.36M	0.58M	0.81M	0.70M	0.60M	0.66M	0.55M	0.72M	0.73M	0.37M	0.58M	0.49M	0.55M	0.86M	0.33M	0.53M	0.41M	0.61M
Depreciation & Amortization (CF) (Quarter)	0.07M	0.08M	0.10M	0.08M	0.10M	0.52M	0.31M	0.32M	0.34M	0.35M	0.42M	0.42M	0.43M	0.43M	0.45M	0.44M	0.43M	0.45M	0.45M	0.73M
Change in Working Capital
Change in Accured Expenses (Quarter)	-3.13M	4.55M	-3.27M	1.92M	-0.69M	2.75M	-0.81M	2.24M	0.97M	1.23M	0.45M	-2.61M	4.53M	-5.59M	9.60M	0.40M	2.02M	1.54M	1.82M	0.55M
Other Working Capital Changes (Quarter)	0.06M	-0.04M	-0.02M	0.03M	0.03M	0.03M	0.04M	0.04M	0.04M	0.04M	0.04M	0.12M	0.04M	0.04M	0.02M	-0.04M	-0.02M	0.06M	-0.01M	0.06M
Investing Activities
Capital Expenditures (Quarter)	0.26M	1.51M	2.69M	1.55M	0.06M	0.41M	0.28M	2.16M	1.33M	1.25M	0.44M	0.42M	0.24M	0.52M	0.18M	0.08M	0.09M	0.30M	0.20M	0.91M
Sales of Property, Plant and Equipment (Quarter)
Change in Intangibles (Quarter)
Acquisitions (Quarter)
Change in Acquisitions & Divestments (Quarter)
Cash from Investing Activities (Quarter)	-0.26M	-1.51M	-2.69M	-1.55M	-0.06M	-0.41M	-0.28M	-2.16M	-1.33M	-1.25M	-0.44M	-0.42M	-0.24M	-0.52M	-0.18M	-0.08M	-0.09M	-0.30M	-0.51M	-0.91M
Financing Activities
Other financing activities (Quarter)
Cash from Financing Activities (Quarter)	10.76M	4.78M	8.92M	23.67M	3.92M	10.41M	16.29M	11.35M	12.58M	8.64M	17.12M	14.41M	12.09M	17.14M	11.62M	15.94M	11.73M	12.45M	11.56M	13.59M
Dividend Payments
Dividends Paid - Common (Quarter)
Additional items
Exchange Rate Effect (Quarter)	0.24M	-0.19M	0.86M	0.46M	0.90M	2.71M	4.70M	-2.80M	-0.78M	-0.64M	1.91M	-1.01M	0.91M	-0.02M	-3.15M	3.55M	-1.62M	-3.92M	3.09M	0.56M
Change in Cash (Quarter)	-2.52M	-3.71M	0.08M	11.33M	-8.21M	-2.13M	4.59M	-2.46M	-0.77M	-4.77M	4.67M	-3.97M	0.35M	0.40M	0.06M	-0.76M	0.60M	1.54M	0.24M	-1.52M
Beginning Cash Balance (Quarter)
Free Cash Flow (Quarter)	-13.51M	-8.30M	-9.70M	-12.80M	-13.03M	-15.25M	-16.39M	-11.01M	-12.57M	-12.77M	-14.36M	-17.38M	-12.64M	-16.72M	-8.41M	-20.26M	-9.51M	-6.99M	-14.10M	-15.67M
Net Cash Flow (Quarter)	-2.75M	-3.52M	-0.78M	10.87M	-9.11M	-4.84M	-0.11M	0.34M	0.01M	-4.13M	2.77M	-2.96M	-0.56M	0.42M	3.21M	-4.32M	2.22M	5.46M	-2.85M	-2.08M

Research Tools

Northwest Biotherapeutics Cash Flow Statement (2010-2025) | NWBO

Create an account

Sign In

Reset Password